Purple Biotech Ltdis A Clinical Stage Company Based In Rehovotisraelfocused On Developing Innovative Cancer Therapiesformerly Known As Kitov Pharma Ltd The Company Rebranded In December 2020 And Is Publicly Traded On Nasdaq And The Tel Aviv Stock Exchange Under The Ticker Symbol Ppbt The Company Aims To Create Effective Treatments That Leverage The Tumor Microenvironment To Address Drug Resistance And Improve Outcomes For Cancer Patientsits Oncology Pipeline Includes Several Candidatessuch As Nt219Which Is In Phase 1 2 Trials For Head And Neck Cancer And Colorectal Adenocarcinomaand Cm24A Monoclonal Antibody In Phase 2 Trials For Pancreatic Cancerpurple Biotech Also Has A Collaboration With Bristol Myers Squibb To Explore The Combination Of Cm24 With A Pd 1 Inhibitor
| Company Name | Purple Biotech Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States